A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response (Q46972228)
Jump to navigation
Jump to search
scientific article published in October 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response |
scientific article published in October 2007 |
Statements
1 reference
A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response (English)
1 reference
1 reference
David R Ferry
1 reference
Mark Anderson
1 reference
Kate Beddard
1 reference
Simon Tomlinson
1 reference
Paul Atherfold
1 reference
Jolanta Obszynska
1 reference
Rebecca Harrison
1 reference
1 October 2007
1 reference
13
1 reference
19
1 reference
5869-5875
1 reference